Seelaus Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $549K | Buy |
9,530
+2,259
| +31% | +$130K | 0.39% | 71 |
|
|
2026
Q1 | $441K | Buy |
7,271
+193
| +3% | +$11.3K | 0.32% | 93 |
|
|
2025
Q4 | $382K | Sell |
7,078
-1,049
| -13% | -$50.5K | 0.3% | 94 |
|
|
2025
Q3 | $367K | Sell |
8,127
-1,099
| -12% | -$51.3K | 0.29% | 99 |
|
|
2025
Q2 | $427K | Sell |
9,226
-174
| -2% | -$8.54K | 0.38% | 84 |
|
|
2025
Q1 | $573K | Sell |
9,400
-591
| -6% | -$34.4K | 0.55% | 55 |
|
|
2024
Q4 | $565K | Sell |
9,991
-1,562
| -14% | -$87.3K | 0.51% | 57 |
|
|
2024
Q3 | $598K | Sell |
11,553
-80
| -0.7% | -$3.75K | 0.55% | 55 |
|
|
2024
Q2 | $483K | Sell |
11,633
-3,979
| -25% | -$178K | 0.49% | 64 |
|
|
2024
Q1 | $847K | Sell |
15,612
-1,599
| -9% | -$81.5K | 0.84% | 27 |
|
|
2023
Q4 | $883K | Sell |
17,211
-1,650
| -9% | -$86.6K | 0.86% | 21 |
|
|
2023
Q3 | $1.09M | Sell |
18,861
-1,069
| -5% | -$65.5K | 1.24% | 12 |
|
|
2023
Q2 | $1.27M | Sell |
19,930
-8,585
| -30% | -$576K | 1% | 18 |
|
|
2023
Q1 | $2M | Sell |
28,515
-3,175
| -10% | -$224K | 1.51% | 9 |
|
|
2022
Q4 | $2.28M | Sell |
31,690
-345
| -1% | -$26K | 1.71% | 9 |
|
|
2022
Q3 | $2.28M | Sell |
32,035
-200
| -0.6% | -$14.5K | 1.81% | 7 |
|
|
2022
Q2 | $2.48M | Sell |
32,235
-549
| -2% | -$41.8K | 1.84% | 6 |
|
|
2022
Q1 | $2.39M | Sell |
32,784
-1,030
| -3% | -$69.2K | 1.42% | 8 |
|
|
2021
Q4 | $2.11M | Sell |
33,814
-7,987
| -19% | -$469K | 1.14% | 14 |
|
|
2021
Q3 | $2.47M | Sell |
41,801
-385
| -0.9% | -$25.4K | 1.45% | 9 |
|
|
2021
Q2 | $2.82M | Sell |
42,186
-7,527
| -15% | -$491K | 1.65% | 7 |
|
|
2021
Q1 | $3.14M | Buy |
49,713
+1,077
| +2% | +$67K | 2.01% | 5 |
|
|
2020
Q4 | $3.02M | Buy |
48,636
+1,172
| +2% | +$72.1K | 2.19% | 5 |
|
|
2020
Q3 | $2.86M | Sell |
47,464
-1,227
| -3% | -$73.8K | 2.3% | 6 |
|
|
2020
Q2 | $2.86M | Buy |
48,691
+1,302
| +3% | +$77.9K | 2.61% | 3 |
|
|
2020
Q1 | $2.64M | Buy |
47,389
+1,481
| +3% | +$90.5K | 3.12% | 3 |
|
|
2019
Q4 | $2.95M | Buy |
45,908
+36,458
| +386% | +$2.09M | 2.38% | 4 |
|
|
2019
Q3 | $479K | Sell |
9,450
-400
| -4% | -$18.8K | 0.42% | 76 |
|
|
2019
Q2 | $447K | Buy |
9,850
+200
| +2% | +$9.32K | 0.4% | 73 |
|
|
2019
Q1 | $460K | Sell |
9,650
-150
| -2% | -$7.47K | 0.43% | 77 |
|
|
2018
Q4 | $509K | Buy |
9,800
+150
| +2% | +$8.06K | 0.55% | 62 |
|
|
2018
Q3 | $599K | Hold |
9,650
| – | – | 0.49% | 68 |
|
|
2018
Q2 | $534K | Hold |
9,650
| – | – | 0.46% | 73 |
|
|
2018
Q1 | $610K | Buy |
9,650
+650
| +7% | +$41.8K | 0.52% | 67 |
|
|
2017
Q4 | $552K | Buy |
+9,000
| New | +$563K | 0.48% | 71 |
|
Other funds holding BMY
AIM
FWIA
DLA
Seelaus Asset Management's BMY Position: Q2 2026 in Review
Seelaus Asset Management increased its Bristol-Myers Squibb (BMY) stake by 31% in Q2 2026, buying an estimated $130K and bringing the position to 9,530 shares worth $549K. The position accounts for 0.39% of the portfolio, ranked #71.
Seelaus Asset Management first reported a position in BMY in Q4 2017 and has held it in 35 quarters since. The position peaked at $3.14M in Q1 2021. 895 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Seelaus Asset Management held 9,530 shares of Bristol-Myers Squibb worth $549K as of Q2 2026.
- Seelaus Asset Management bought 2,259 Bristol-Myers Squibb shares in Q2 2026, an estimated $130K.
- Bristol-Myers Squibb made up 0.39% of Seelaus Asset Management's portfolio in Q2 2026, its #71 holding.
- Seelaus Asset Management first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 35 quarters since.
- Seelaus Asset Management's Bristol-Myers Squibb position peaked at $3.14M in Q1 2021.
- 895 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Seelaus Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.